Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Symptomatic Treatment of Vascular Cognitive Impairment

NCT02098824 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.

NCT NCT02098824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02098824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Symptomatic Treatment of Vascular Cognitive Impairment
Lead sponsor
Amsterdam UMC, location VUmc
Phase
Phase 2/3
Overall status
Unknown status
Start date
February 28, 2014
Completion date
July 31, 2017
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive disorder (vascular), mild cognitive impairment (vascular), vascular dementia